177 related articles for article (PubMed ID: 7504575)
1. Clinical considerations in the use of risperidone.
Remington GJ
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S96-100. PubMed ID: 7504575
[TBL] [Abstract][Full Text] [Related]
2. Clinical review of risperidone.
Chouinard G; Arnott W
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S89-95. PubMed ID: 7504574
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
Kopala LC; Honer WG
J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
[No Abstract] [Full Text] [Related]
4. Pathophysiology and treatment of negative symptoms.
Villeneuve A
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S53-8. PubMed ID: 7533052
[TBL] [Abstract][Full Text] [Related]
5. Risperidone: clinical safety and efficacy in schizophrenia.
Borison RL; Pathiraja AP; Diamond BI; Meibach RC
Psychopharmacol Bull; 1992; 28(2):213-8. PubMed ID: 1381102
[TBL] [Abstract][Full Text] [Related]
6. New antipsychotic medications: do research results relate to clinical practice?
MacEwan GW
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S75-9. PubMed ID: 7504572
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.
Möller HJ; Pelzer E; Kissling W; Riehl T; Wernicke T
Pharmacopsychiatry; 1991 Nov; 24(6):185-9. PubMed ID: 1725925
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic medication in the treatment of schizophrenia.
Kane JM
Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
[TBL] [Abstract][Full Text] [Related]
9. Novel neuroleptics in schizophrenia: theory and clinical relevance.
Remington GJ
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
[No Abstract] [Full Text] [Related]
10. Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug.
Keegan D
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S46-52. PubMed ID: 7533051
[TBL] [Abstract][Full Text] [Related]
11. New drug offers hope for people with schizophrenia.
J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):46. PubMed ID: 7519676
[No Abstract] [Full Text] [Related]
12. Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
Jacobsen FM
J Clin Psychiatry; 1995 Sep; 56(9):423-9. PubMed ID: 7545159
[TBL] [Abstract][Full Text] [Related]
13. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
[TBL] [Abstract][Full Text] [Related]
14. Ethical issues in drug selection for schizophrenia.
Jeffries JJ
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S70-4. PubMed ID: 7504571
[TBL] [Abstract][Full Text] [Related]
15. Risperidone in adolescents.
Cozza SJ; Edison DL
J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1211. PubMed ID: 7527022
[No Abstract] [Full Text] [Related]
16. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
17. Extrapyramidal side effects and tolerability of risperidone: a review.
Owens DG
J Clin Psychiatry; 1994 May; 55 Suppl():29-35. PubMed ID: 7520906
[TBL] [Abstract][Full Text] [Related]
18. Negative symptoms in schizophrenia: assessment of the effect of risperidone.
Schooler NR
J Clin Psychiatry; 1994 May; 55 Suppl():22-8. PubMed ID: 7520905
[TBL] [Abstract][Full Text] [Related]
19. [New chemotherapy approaches to psychoses].
Olié JP; Baylé FJ
Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy of schizophrenia: a review.
Sigmundson HK
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
